Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Orlistat

Xenical, Alli, Beacita

Bibliografia - Quali fonti bibliografiche per Orlistat?

1. Asberg A., Drugs, 2003, 63 (4), 367.

2. Barbaro D. et al., Endocr. Pract., 2002, 8 (2), 124.

3. Beaver J et al., 1st International Congress on Abdominal Obesity, 2010, 28-30 gennaio, Honk Kong, Cina.

4. Bigham S. et al., Epilepsia, 2006, 47 (12), 2207.

5. Borgstrom B., Biochim. Biophys. Acta, 1988, 962, 308.

6. Bryson A. et al., Br. J. Clin. Pharmacol., 2009, 67 (3), 309.

7. Chaikomin R. et al., Br. J. Nutr., 2006, 96 (5), 883.

8. Chanoine J.P. et al., JAMA, 2005, 293 (23), 2873.

9. Czerwienska B. et al., Pol. Arch. Med. Wewn., 2004, 112 (6), 1415.

10. Didangelos T.P. et al., Curr. Med. Res. Opin., 2004, 20 (9), 1393.

11. Du J., Wang Z., Med. Hypotheses, 2009, 73 (5), 662.

12. Evans S. et al., Am. J. Kidney Dis., 2003, 41 (2), 493.

13. Filippatos T.D. et al., Drug Saf., 2008, 31 (1), 53.

14. Hadvary et al., Biochem. J., 1988, 256, 357.

15. Hartmann D. et al., Eur. J. Clin. Pharmacol., 1996, 50 (5), 421.

16. Heck A.M. et al., Ann. Pharmacother., 2002, 36 (6), 1003.

17. Hilger E. et al., J. Clin. Psychopharmacol., 2002, 22 (1), 68.

18. Holecki M. et al., Int. J. Obes. (Lond.), 2006, 30 (6), 1017.

19. Karamadoukis L. et al., Clin. Nephrol., 2009, 71 (4), 430.

20. Kelley D.E. et al., Diabetes Care, 2004, 27 (1), 33.

21. Kopelman P. et al., Obesity (Silver Spring), 2010, 18 (1), 108.

22. MacWalter R.S. et al., Ann. Pharmacother., 2003, 37 (4), 510.

23. Melia A.T. et al., J. Clin. Pharmacol., 1995, 35 (8), 840.

24. Melia A.T. et al., J. Clin. Pharmacol., 1996, 36 (4), 352.

25. Melia A.T. et al., J. Clin. Pharmacol., 1996a, 36 (7), 654.

26. Nägele H. et al., Eur. J. Clin. Pharmacol., 1999, 55 (9), 667.

27. O’Connor M.B., Ir. J. Med. Sci., 2010, 179 (2), 315.

28. Padwal R. et al., Int. J. Obes. Relat. Metab. Disord., 2003, 27 (12), 1437.

29. Persson M., Vitols S., BMJ, 2000, 321, 87.

30. Ringman J.M., Mozaffar T., Neuromuscul. Disord., 2008, 18 (5), 410.

31. Sarica K. et al., Obesity (Silver Spring), 2008, 16 (7), 1579.

32. Sharma A.M., Golay A., J. Hypertens., 2002, 20, 1873.

33. Shi Y.F. et al., Diabet. Med., 2005, 22 (12), 1737.

34. Sjöström L. et al., Lancet, 1998, 352 (9123), 167.

35. Sundl I. et al., Lipids, 2006, 41 (2), 113.

36. Toplak H. et al., Diabetes Obes. Metab., 2005, 7 (6), 699.

37. Torgerson J.S. et al., Diabetes Care, 2004, 27 (1), 155.

38. Valsecia M.E. et al., Ann. Pharmacother., 2001, 35, 1496.

39. Weber C. et al., Eur. J. Clin. Pharmacol., 1996, 51 (1), 87.

40. Weibel et al., J. Antibiot. Tokyo, 1987, 40, 1081.

41. Wirth A., Diabetes Obes. Metab., 2005, 7 (1), 21.

42. Zhi J. et al., Clin. Pharmacol. Ther., 1994, 56, 82.

43. Zhi J. et al., J. Clin. Pharmacol., 1995, 35, 1103.

44. Zhi J. et al., J. Clin. Pharmacol., 1995a, 35 (5), 521.

45. Zhi J. et al., J. Clin. Pharmacol., 1996, 36 (7), 659.

46. Zhi J. et al., J. Clin. Pharmacol., 1996a, 36 (11), 1006.

47. Zhi J. et al., J. Clin. Pharmacol., 2002, 42 (9), 1011-9.

48. Zhi J. et al., J. Clin. Pharmacol., 2003, 43 (4), 428.

49. Zhi J. et al., J. Am. Coll. Nutr., 2003a, 22 (5), 357.